|
Day One: Thursday, April 15
Main Conference
11:30 Main Conference
Registration
12:40 Chairperson's
Opening Remarks
Jeff Hewitt, Partner,
Strategic Decisions Group
12:45 What is the
Best Organizational Structure for Managing Collaborations?
• What information should
you agree upon sharing?
• Is line functions or a
new, alliance management department more effective?
• What is the role of
Alliance Management?
Ian McKenna, Alliance
Manager, Office of Alliance Management, Eli Lilly and Company
1:30 Steps to Ensure
a Collaboration Success
• Identify pathways to
success
• Communication keys to
unlock potential
• Individual vs Shared
responsibilities
• Conflict Resolution
Mark Coflin, Global
Director, BDL Alliance Management, Novartis
2:15 Steps to Take
for Commercial Success
• Create an organized
post-deal process that is thorough but finite
• Define and implement a
governance model to suit partners' needs
• Translate the contract
into an operational relationship guide
• Define measures of
success for the partnership and agree on a periodic audit mechanism
• Dedicate a trained
alliance management team to keep process moving
Pamela Demain,
Executive Director, Corporate Licensing, Merck & Co.
3:00 Networking
Refreshment Break
3:30 Creating
Synergies for International Alliances
• Understanding cultural
differences
• Protecting intellectual
property
• Implementing a process
to exchange information efficiently
• Defining regular
meetings between senior management not initiated by conflicts or problems
but by a planned schedule
Maggie Flanagan,
Ph.D., Global Alliance Director, Enabling Science, Technology and
Information, AstraZeneca Pharmaceuticals
4:15 Drafting the
Agreement - Collaboration Governance and Protection of Intellectual Property
• Outlining collaboration
governance components including: committees, alliance managers and executive
champions
• Shaping the strategic &
operational decision making process
• Authoring an outline
for dispute resolution
• Determining ownership
and rights to new intellectual property including: pre-existing IP,
improvements to pre-existing IP, platform technologies, new indications
(therapeutics uses, diagnostic uses) and responsibility for patents
Paul Thompson, Ph.D.,
Senior Legal Director, Licensing, Schering-Plough Corporation
5:00 Forming a
Collaboration Between Your Business and a Successful Intellectual Asset
Management (IAM) Process
• Recognizing a
methodology that will eliminate well known gaps in IAM processes
• Utilizing this
recognition to truly understand your business objectives and uncover all
"hidden" and existing intellectual property (IP)
• Executing your business
objectives by using best in class, novel, IAM methods and IP strategies
• Gaining economic value
from your aligned business/IP story (i.e. license in/out, M&A, JV, increase
market share, wall street, etc.)
John E. Cronin, Managing
Director and Chairman, ipCapital Group, Inc.
5:45 Networking
Cocktail Reception and One-to-One Meetings
Sponsored by
6:45 Close of Day One
|
